Ridinilazole
CAS No. 308362-25-6
Ridinilazole ( SMT19969 )
产品货号. M22106 CAS No. 308362-25-6
Ridinilazole is a novel narrow-spectrum nonabsorbable antibiotic.
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
规格 | 价格/人民币 | 库存 | 数量 |
2MG | ¥1069 | 有现货 |
|
5MG | ¥1596 | 有现货 |
|
10MG | ¥2730 | 有现货 |
|
25MG | ¥4633 | 有现货 |
|
50MG | ¥6626 | 有现货 |
|
100MG | ¥9153 | 有现货 |
|
200MG | 获取报价 | 有现货 |
|
500MG | 获取报价 | 有现货 |
|
1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称Ridinilazole
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述Ridinilazole is a novel narrow-spectrum nonabsorbable antibiotic.
-
产品描述Ridinilazole is a novel narrow-spectrum nonabsorbable antibiotic. Ridinilazole showed potent inhibition of C. difficile (MIC90=0.125 mg/L) and was markedly more active than either metronidazole (MIC90?=?8 mg/L) or vancomycin (MIC90?=?2 mg/L).ridinilazole , a novel antibacterial currently under development for the treatment of CDI.?Owing to its highly targeted spectrum of activity and ability to spare the normal gut microbiota, ridinilazole provides significant advantages over metronidazole and vancomycin, the mainstay antibiotics for CDI.?Ridinilazole is bactericidal against C. difficile and exhibits a prolonged post-antibiotic effect.?Furthermore, treatment with ridinilazole results in decreased toxin production.
-
同义词SMT19969
-
通路GPCR/G Protein
-
靶点Antibacterial
-
受体Antibacterial
-
研究领域Immune system
-
适应症Clostridium Difficile Infection
化学信息
-
CAS Number308362-25-6
-
分子量388.42
-
分子式C24H16N6
-
纯度>98% (HPLC)
-
溶解度DMSO:55 mg/mL (141.6 mM)
-
SMILESc1cc(ccn1)-c1nc2cc(ccc2[nH]1)-c1ccc2[nH]c(nc2c1)-c1ccncc1
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Vickers RJ, et al. Ridinilazole: a novel therapy for Clostridium difficile infection. Int J Antimicrob Agents. 2016 Aug;48(2):137-43.
产品手册
关联产品
-
Relebactam
Relebactam (MK-7655)is a novel β-lactamase inhibitor that inhibited both class A and C β-lactamases in vitro.
-
Ciprofloxacin hydroc...
Ciprofloxacin hydrochloride hydrate is a fluoroquinolone antibioticis an antibiotic used to treat a number of bacterial infections.
-
NSC624548
A small molecule that inhibits the activities of E. coli DNA polymerase I and calf thymus DNA polymerase alpha.